Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance (Q33845880)

29 July 2017

1 reference

title

Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance (English)

1 reference

eradication of infectious diseases

29 July 2017

main subject

1 reference

inferred from title

Streptococcus pneumoniae

1 reference

1 reference

Gotfried MH

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

published in

Clinical Therapeutics

1 reference

29 July 2017

volume

22

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

2-14

1 reference

Community-acquired pneumonia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Antimicrobial resistance in community-acquired respiratory tract pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Immunization policies and vaccine coverage among adults. The risk for missed opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Antimicrobial treatment in acute maxillary sinusitis: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Susceptibility of pneumococci to nine antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Effects of environmental factors on the in vitro potency of azithromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987973-4

7 January 2021

10.1016/S0149-2918(00)87973-4

Identifiers

DOI

1 reference

29 July 2017

1 reference